Rare diseases
Investigational molecules
Locations
Study of Weekly Oral GS-1720 and GS-4182 for People with HIV-1 Who Are Virologically Suppressed
FranceStudy on HIV-1 Treatment for Patients New to Therapy: Comparing Doravirine/Islatravir with a Drug Combination
FranceStudy on Switching HIV Treatment to Doravirine and Islatravir for Patients with HIV-1
FranceStudy of Tenofovir Alafenamide for Children and Teens with Chronic Hepatitis B
RomaniaPhase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus
BulgariaStudy on the Safety and Effectiveness of Emtricitabine and Tenofovir Alafenamide for HIV-1 Prevention in Men and Transgender Women at Risk
AustriaStudy on the Effects of Ianalumab in Patients with Sjögren's Syndrome
FranceStudy of Weekly Oral GS-1720 and GS-4182 for Untreated HIV-1 Patients
GermanyStudy on Stopping Tenofovir Alafenamide, Tenofovir Disoproxil, and Entecavir in Patients with Chronic Hepatitis B
BelgiumStudy Comparing Weekly Islatravir/Lenacapavir Regimen to Standard Care in HIV Patients with Controlled Viral Load
GermanyStudy on Dolutegravir and Lamivudine for Maintaining Viral Control in Children with HIV Aged 2 to Under 15 Years
SpainStudy to Compare Weekly Islatravir/Lenacapavir with Bictegravir/Emtricitabine/Tenofovir in People with HIV-1 Who Are Virologically Suppressed
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
